Literature DB >> 15626879

The use of phosphodiesterase type 5 inhibitors for erectile dysfunction.

Francesco Montorsi1, Alberto Briganti, Andrea Salonia, Piero Montorsi, Patrizio Rigatti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15626879     DOI： 10.1097/00042307-200411000-00011

Source DB:  PubMed          Journal:  Curr Opin Urol        ISSN： 0963-0643            Impact factor:   2.309


× No keyword cloud information.
  2 in total

1.  Effect of the phosphodiesterase 5 inhibitors sildenafil, tadalafil and vardenafil on rat anococcygeus muscle: functional and biochemical aspects.

Authors:  Haroldo A Toque; Fernanda B M Priviero; Saiprasad M Zemse; Edson Antunes; Cleber E Teixeira; R Clinton Webb
Journal:  Clin Exp Pharmacol Physiol       Date:  2008-10-15       Impact factor: 2.557

2.  Vardenafil, but not sildenafil or tadalafil, has calcium-channel blocking activity in rabbit isolated pulmonary artery and human washed platelets.

Authors:  H A Toque; C E Teixeira; F B M Priviero; R P Morganti; E Antunes; G De Nucci
Journal:  Br J Pharmacol       Date:  2008-04-21       Impact factor: 8.739
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.